Dozens of research papers and large-scale trials are evidence that interest in immunotherapy is growing among oncologists, according to an editorial published in the International Journal of Radiation Oncology • Biology • Physics, but that research won’t be able to grow without universal adherence to quality assurance (QA) standards for radiation therapy. For now, at least, that’s not the reality.